Every story in this section, newest first — page 254 of 373.
Tencent Music Entertainment Group (NYSE:TME) delivered a robust financial performance for the fourth quarter and full year of 2025, underscored by the rapid expansion of its premium subscriber base.
Huya (NYSE:HUYA) reported unaudited financial results for the fourth quarter and full year ended December 31, 2025, revealing a strategic shift toward game-related services that has returned the company to top-line growth.
NCR Voyix (NYSE:VYX) today announced it has entered into a definitive agreement to sell its bank technology solutions business in Japan to Tokyo-based NTT DATA.
Zenas BioPharma (NASDAQ:ZBIO) announced its full-year 2025 financial results on March 16, 2026, marking a pivotal year that has positioned the Waltham, Massachusetts-based biotech for its first potential product launch.
Contango ORE (NYSE:CTGO) filed its annual report on Form 10-K for the fiscal year ended December 31, 2025, detailing the company's successful transition from explorer to producer.
Getty Images (NYSE:GETY) reported its financial results for the fourth quarter and full year ended December 31, 2025, delivering the highest annual revenue in the company’s history.
Silvercrest Asset Management Group (NASDAQ:SAMG) announced its financial results for the fourth quarter and full year ended December 31, 2025, on March 16, 2026.
TriMas (NASDAQ:TRS) announced on March 16, 2026, the successful completion of the sale of TriMas Aerospace to PennAero, a portfolio company of Tinicum and funds managed by Blackstone.
VinFast Auto (NASDAQ:VFS) released its preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025, highlighting a year of rapid industrial scaling and increasing international footprint.
IHS Holding (NYSE:IHS), one of the world's largest independent telecommunications infrastructure developers, reported its fourth-quarter and full-year 2025 financial results on March 16, 2026.
Bitcoin Depot (NASDAQ:BTM), the largest Bitcoin ATM operator in North America, reported its full-year 2025 financial results, showcasing significant gains in operational efficiency and profitability.
Olema Oncology (NASDAQ:OLMA) announced its fourth-quarter and full-year 2025 financial results on Monday, highlighting a year of substantial capital formation and clinical acceleration.
Relay Therapeutics (NASDAQ:RLAY) announced clinical data from its Phase 1/2 ReDiscover trial on Monday, providing a significant update on the efficacy and safety of zovegalisib (formerly RLY-2608).
Telos (NASDAQ:TLS) reported its fourth-quarter and full-year 2025 financial results on March 16, 2026, delivering a "beat and raise" performance that underscores the company’s successful pivot toward higher-margin security software.
Canopy Growth (NASDAQ:CGC) and MTL Cannabis announced the successful closing of their previously disclosed arrangement on Monday.
Annovis Bio (NYSE:ANVS) reported its full-year 2025 financial results and clinical milestones on March 16, 2026, highlighting a period of aggressive execution for its neurodegenerative disease pipeline.
Nasus Pharma (NYSE:NSRX) announced positive topline results from its Phase 2 clinical study of NS002, a proprietary intranasal epinephrine powder designed to treat life-threatening allergic reactions.
Nebius (NASDAQ:NBIS) shares surged 13% to $128.08 in premarket trading on Monday following the announcement of a landmark five-year agreement with Meta Platforms (NASDAQ:META).
Agenus (NASDAQ:AGEN) reported its financial results for the fourth quarter and full year ended December 31, 2025, marking a transition from a purely clinical-stage company to one generating initial pre-commercial revenue.
Bitdeer Technologies Group (NASDAQ:BTDR) released its unaudited mining and operations update for February 2026, highlighting its position as a dominant force in the global digital asset and AI infrastructure landscape.
Meta Platforms (NASDAQ:META) shares rose 3% in premarket trading on Monday following reports that the company is considering laying off at least 20% of its workforce.
Tilray Brands (NASDAQ:TLRY) on Monday announced it has entered into an asset purchase agreement to acquire key BrewDog operating assets in the United States, including the Columbus, Ohio brewery, three Ohio pubs, a Columbus hotel, the Las Vegas flagship brewpub, a franchised Denver location and a licensed site at Columbus airport.
CytomX Therapeutics (NASDAQ:CTMX) reported its full-year 2025 financial results and a strategic business update on March 16, 2026, highlighting the continued evolution of its Probody® platform.
Science Applications International Corp. (NASDAQ:SAIC) reported its fiscal fourth quarter and full-year 2026 results on March 16, 2026, showcasing a company in the midst of a significant structural and leadership transition.
